Application of circulating tumor DNA in prospective clinical oncology trials – standardization of preanalytical conditions

Circulating tumor DNA (ctDNA) has emerged as a potential new biomarker with diagnostic, predictive, and prognostic applications for various solid tumor types. Before beginning large prospective clinical trials to prove the added value of utilizing ctDNA in clinical practice, it is essential to inves...

全面介紹

Na minha lista:
書目詳細資料
發表在:Mol Oncol
Main Authors: van Dessel, Lisanne F., Beije, Nick, Helmijr, Jean C.A., Vitale, Silvia R., Kraan, Jaco, Look, Maxime P., de Wit, Ronald, Sleijfer, Stefan, Jansen, Maurice P.H.M., Martens, John W.M., Lolkema, Martijn P.
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2017
主題:
Research Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527445/
https://ncbi.nlm.nih.gov/pubmed/28164427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12037
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍